story of the week
Association of SGLT-2 Inhibitors and Euglycemic Diabetic Ketoacidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition
Diabetes Care 2015 Jun 15;[EPub Ahead of Print], AL Peters, EO Buschur, JB Buse, P Cohan, JC Diner, IB HirschFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.